跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,115 条关于
“microtubule-binding region”
全部
14,115
临床试验
9,336
药物
272
机构
180
资讯
4,327
11个月前
Bristol Myers Squibb's Anti-Tau Antibody BMS-986446 Receives FDA Fast Track Designation for Alzheimer's Disease
去年
Eisai's Anti-MTBR Tau Antibody E2814 Shows Promise in Early Alzheimer's Disease
去年
UCB's Bepranemab Shows Promise in Phase 2a Alzheimer's Disease Trial
10个月前
Bristol-Myers Squibb Exercises $2.2 Billion Option on Prothena's Tau-Targeting Alzheimer's Antibody
去年
Eisai's Anti-MTBR Tau Antibody E2814 Shows Promise in Alzheimer's Disease
去年
Eisai's Tau Antibody Etalanetug Receives FDA Fast Track Designation for Alzheimer's Disease
去年
UCB's Bepranemab Shows Promise in Reducing Tau Tangles in Alzheimer's Subgroup
7个月前
Prothena Reports Q4 2025 Results as Neurodegeneration Pipeline Advances with Major Partnerships
3个月前
Advances in Alzheimer's Disease Treatment: From Anti-Amyloid Antibodies to Multi-Target Strategies
去年
FDA's Draft Guidance on Clinical Trial Diversity: Challenges and Implications for Pharma
第 1 页，共 433 页
上一页
下一页
